141 related articles for article (PubMed ID: 24213325)
1. An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications.
Qi XS; Yang Q; Lee SP; Li XA; Wang D
Cancers (Basel); 2012 Jun; 4(2):566-80. PubMed ID: 24213325
[TBL] [Abstract][Full Text] [Related]
2. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).
Wang JZ; Li XA; D'Souza WD; Stewart RD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):543-52. PubMed ID: 12957268
[TBL] [Abstract][Full Text] [Related]
3. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
4. In vitro study of cell survival following dynamic MLC intensity-modulated radiation therapy dose delivery.
Moiseenko V; Duzenli C; Durand RE
Med Phys; 2007 Apr; 34(4):1514-20. PubMed ID: 17500482
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study.
Duan J; Shen S; Fiveash JB; Popple RA; Brezovich IA
Med Phys; 2006 May; 33(5):1380-7. PubMed ID: 16752574
[TBL] [Abstract][Full Text] [Related]
6. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
7. Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing.
Zheng XK; Chen LH; Yan X; Wang HM
World J Gastroenterol; 2005 Mar; 11(10):1452-6. PubMed ID: 15770720
[TBL] [Abstract][Full Text] [Related]
8. In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells.
Wang JZ; Rhee JG; Shi P; Stewart RD; Allen Li X
Int J Radiat Biol; 2008 Jun; 84(6):515-22. PubMed ID: 18470750
[TBL] [Abstract][Full Text] [Related]
9. Biological effect of different IMRT delivery techniques: SMLC, DMLC, and helical tomotherapy.
Shaikh M; Burmeister J; Joiner M; Pandya S; Zhao B; Liu Q
Med Phys; 2010 Feb; 37(2):762-70. PubMed ID: 20229886
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
11. Significant dose can be lost by extended delivery times in IMRT with x rays but not high-LET radiations.
Joiner MC; Mogili N; Marples B; Burmeister J
Med Phys; 2010 Jun; 37(6):2457-65. PubMed ID: 20632556
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.
Mohan R; Wu Q; Manning M; Schmidt-Ullrich R
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):619-30. PubMed ID: 10701741
[TBL] [Abstract][Full Text] [Related]
13. Coplanar versus noncoplanar intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) treatment planning for fronto-temporal high-grade glioma.
Panet-Raymond V; Ansbacher W; Zavgorodni S; Bendorffe B; Nichol A; Truong PT; Beckham W; Vlachaki M
J Appl Clin Med Phys; 2012 Jul; 13(4):3826. PubMed ID: 22766954
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric and radiobiological comparison in head-and-neck radiotherapy using JO-IMRT and 3D-CRT.
Tai DT; Oanh LT; Phuong PH; Sulieman A; Abolaban FA; Omer H; Chow JCL
Saudi J Biol Sci; 2022 Aug; 29(8):103336. PubMed ID: 35754762
[TBL] [Abstract][Full Text] [Related]
15. Clinical radiobiology of head and neck cancer: the hypothesis of stem cell activation.
Pedicini P; Caivano R; Fiorentino A; Strigari L
Clin Transl Oncol; 2015 Jun; 17(6):469-76. PubMed ID: 25487602
[TBL] [Abstract][Full Text] [Related]
16. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
17. Loss of radiobiological effect of imaging dose in image guided radiotherapy due to prolonged imaging-to-treatment times.
Flynn RT
Med Phys; 2010 Jun; 37(6):2761-9. PubMed ID: 20632586
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological evaluation of forward and inverse IMRT using different fractionations for head and neck tumours.
Ferreira BC; do Carmo Lopes M; Mateus J; Capela M; Mavroidis P
Radiat Oncol; 2010 Jun; 5():57. PubMed ID: 20569482
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time.
Hedman M; Björk-Eriksson T; Brodin O; Toma-Dasu I
Br J Radiol; 2013 May; 86(1025):20130015. PubMed ID: 23479396
[TBL] [Abstract][Full Text] [Related]
20. Prospective Evaluation of Taste Function in Patients With Head and Neck Cancer Receiving Intensity-Modulated Radiotherapy.
Chen WC; Hsu CM; Tsai YT; Lin MH; Tsai MS; Chang GH; Lai CH; Fang F; Chen MF
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):604-611. PubMed ID: 35616981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
